CoChat

Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells

van der Hoek, Joost, Waaijers, Marlijn, van Koetsveld, Peter M., Sprij-Mooij, Diana, Feelders, Richard A., Schmid, Herbert A., Schoeffter, Philippe, Hoyer, Daniel, Cervia, Davide, Taylor, John E., Culler, Michael D., Lamberts, Steven W. J., Hofland, Leo J. · 2005 · American Journal of Physiology-Endocrinology and Metabolism
Cited by 152

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

In a series of human corticotroph adenomas, we recently found predominant mRNA expression of somatostatin (SS) receptor subtype 5 (sst 5). After 72 h, the multiligand SS analog SOM230, which has a very high sst 5 binding affinity, but not Octreotide (OCT), significantly inhibited basal ACTH release. To further explore the role of sst 5 in the regulation of ACTH release, we conducted additional studies with mouse AtT-20 cells. SOM230 showed a 7-fold higher ligand binding affinity and a 19-fold higher potency in stimulating guanosine 5′- O-(3-thiotriphosphate) binding in AtT-20 cell membranes compared with OCT. SOM230 potently suppressed CRH-induced ACTH release, which was not affected by 48-h dexamethasone (DEX) pretreatment. However, DEX attenuated the inhibitory effects of OCT on ACTH release, whereas it increased the inhibitory potency of BIM-23268, an sst 5-specific analog, on ACTH release. Quantitative PCR analysis showed that DEX lowered sst 2A+2B mRNA expression significantly after 24 and 48 h, whereas sst 5 mRNA levels were not significantly affected by DEX treatment. Moreover, Scatchard analyses showed that DEX suppressed maximum binding capacity (B max) by 72% when 125 I-Tyr 3-labeled OCT was used as radioligand, whereas B max declined only by 17% when AtT-20 cells were treated with [125 I-Tyr 11]SS-14. These data suggest that the sst 5 protein, compared with sst 2, is more resistant to glucocorticoids. Finally, after SS analog preincubation, compared with OCT both SOM230 and BIM-23268 showed a significantly higher inhibitory effect on CRH-induced ACTH release. In conclusion, our data support the concept that the sst 5 receptor might be a target for new therapeutic agents to treat Cushing’s disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpendo.00004.2005

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 152

Metadata

Authors
van der Hoek, J., Waaijers, M., van Koetsveld, P. M., Sprij-Mooij, D., Feelders, R. A., Schmid, H. A., Schoeffter, P., Hoyer, D., Cervia, D., Taylor, J. E., Culler, M. D., Lamberts, S. W. J., & Hofland, L. J.
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2005-08
Volume
289
Issue
2
Pages
E278-E287
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2118708995
Cited by
152
References
2
FWCI
6.57
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells. https://app.cochat.ai/papers/10.1152/ajpendo.00004.2005
The paper
van der Hoek, J., Waaijers, M., van Koetsveld, P. M., Sprij-Mooij, D., Feelders, R. A., Schmid, H. A., Schoeffter, P., Hoyer, D., Cervia, D., Taylor, J. E., Culler, M. D., Lamberts, S. W. J., & Hofland, L. J. (2005). Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.00004.2005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.